Overview

Liposomal Bupivacaine vs Peripheral Nerve Block

Status:
Terminated
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
Liposomal bupivacaine has gained interest in recent literature for its potential to be an effective adjunct to other pain control modalities in a multi-modal approach to post-operative pain control. The goal of this investigation is to compare the efficacy of local administration of liposomal bupivacaine versus the efficacy of a peripheral nerve block in terms of post-operative pain scores after elective ankle and hindfoot surgery. The investigators hypothesize that there will not be a significant difference in the pain scores of these two groups in opioid naïve patients.
Phase:
Phase 4
Details
Lead Sponsor:
Gerard Cush
Treatments:
Bupivacaine